AAO 2024 Insights
- Retina & Vitreous
- Uveitis
- Cornea & External Disease
- Cataract & Lens
- Oculoplastics
- Pediatric & Strabismus
- Glaucoma
- Neuro-Ophthalmology
- Business
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
AAO 2024 Insights: One Year Results of Treatment-Experienced Neovascular Age Related Macular Degeneration (AMD) Patients Switched to Faricimab
By
AAO 2024 Insights
FEATURING
Sean Adrean
By
AAO 2024 Insights
FEATURING
Sean Adrean
189 views
October 23, 2024
Comments 0
Login to view comments.
Click here to Login
Retina & Vitreous